Editorial
doi: 10.1159/000108591.
Epub 2007 Sep 17.
Optimizing management of recurrent epithelial ovarian cancer: a critical need for evidence-based data
- PMID: 17873498
- DOI: 10.1159/000108591
Item in Clipboard
Editorial
Optimizing management of recurrent epithelial ovarian cancer: a critical need for evidence-based data
Oncology.
2006.
No abstract available
Comment on
-
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study.Oncology. 2006;71(5-6):320-6. doi: 10.1159/000108592. Epub 2007 Sep 18. Oncology. 2006. PMID: 17878745
Similar articles
-
Current management of epithelial carcinoma of the ovary.Compr Ther. 1985 May;11(5):52-9. Compr Ther. 1985. PMID: 4006423 No abstract available.
-
Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study.Gynecol Oncol. 2009 Feb;112(2):384-8. doi: 10.1016/j.ygyno.2008.11.001. Epub 2008 Dec 6. Gynecol Oncol. 2009. PMID: 19059635 Clinical Trial.
-
Ovarian carcinoma: an optimistic epilogue.Cancer Treat Rep. 1979 Feb;63(2):333-7. Cancer Treat Rep. 1979. PMID: 376138 Clinical Trial. No abstract available.
-
The role of targeted therapy in ovarian cancer.Eur J Cancer. 2011 Sep;47 Suppl 3:S116-30. doi: 10.1016/S0959-8049(11)70155-1. Eur J Cancer. 2011. PMID: 21943965 Review.
-
Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancer.Eur J Cancer. 2011 Sep;47 Suppl 3:S104-15. doi: 10.1016/S0959-8049(11)70154-X. Eur J Cancer. 2011. PMID: 21943964 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
